Paper36980704
Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling.
Doppelt-Flikshtain O and 9 others. Cancers (Basel), 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling. Papers, record 36980704. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980704
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Endothelial Progenitor Cells Promote Osteosarcoma Progression and Invasiveness via AKT/PI3K Signaling.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 20200122 | Israel Cancer Association | PubMed | ||
| NA | The Rappaport Institute, Rappaport Faculty of Medicine, Technion, Haifa, Israel | PubMed |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34069999 | Targeting the VEGF Pathway in Osteosarcoma. | Cells | 2021 | https://conductscience.org/library/papers/34069999 | PubMed |
| 2 | 28495397 | Safety profile and long-term engraftment of human CD31+ blood progenitors in bone tissue engineering. | Cytotherapy | 2017 | https://conductscience.org/library/papers/28495397 | PubMed |
| 3 | 23257830 | VEGF levels and the angiogenic potential of the microenvironment can affect surgical strategy for colorectal liver metastasis. | Cell Adh Migr | 2012 | https://conductscience.org/library/papers/23257830 | PubMed |
| 4 | 32472305 | Pemigatinib: First Approval. | Drugs | 2020 | https://conductscience.org/library/papers/32472305 | PubMed |
| 5 | 14699017 | Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. | Arterioscler Thromb Vasc Biol | 2004 | https://conductscience.org/library/papers/14699017 | PubMed |
| 6 | 31717420 | Predicting Angiogenesis by Endothelial Progenitor Cells Relying on In-Vitro Function Assays and VEGFR-2 Expression Levels. | Biomolecules | 2019 | https://conductscience.org/library/papers/31717420 | PubMed |
| 7 | 25351625 | LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro. | Mol Med Rep | 2015 | https://conductscience.org/library/papers/25351625 | PubMed |
| 8 | 29490434 | Endothelial progenitor cells contribute to neovascularization of non-small cell lung cancer via histone deacetylase 7-mediated cytoskeleton regulation and angiogenic genes transcription. | Int J Cancer | 2018 | https://conductscience.org/library/papers/29490434 | PubMed |
| 9 | 28374486 | A Novel CXCR4 antagonist enhances angiogenesis via modifying the ischaemic tissue environment. | J Cell Mol Med | 2017 | https://conductscience.org/library/papers/28374486 | PubMed |
| 10 | 26917455 | Significance and therapeutic implications of endothelial progenitor cells in angiogenic-mediated tumour metastasis. | Crit Rev Oncol Hematol | 2016 | https://conductscience.org/library/papers/26917455 | PubMed |
| 11 | 30383677 | Prognostic significance of matrix metalloproteinase 9 expression in osteosarcoma: A meta-analysis of 16 studies. | Medicine (Baltimore) | 2018 | https://conductscience.org/library/papers/30383677 | PubMed |
| 12 | 24455551 | Osteosarcoma relapse as pleural metastasis. | South Asian J Cancer | 2013 | https://conductscience.org/library/papers/24455551 | PubMed |
| 13 | 20465783 | Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. | BMC Med Genomics | 2010 | https://conductscience.org/library/papers/20465783 | PubMed |
| 14 | 33655556 | Inhibition of FGF-FGFR and VEGF-VEGFR signalling in cancer treatment. | Cell Prolif | 2021 | https://conductscience.org/library/papers/33655556 | PubMed |
| 15 | 21609465 | Endothelial progenitor cell biology in disease and tissue regeneration. | J Hematol Oncol | 2011 | https://conductscience.org/library/papers/21609465 | PubMed |
| 16 | 16896870 | Current strategies of chemotherapy in osteosarcoma. | Int Orthop | 2006 | https://conductscience.org/library/papers/16896870 | PubMed |
| 17 | 31203572 | FGF-2 Attenuates Neuronal Apoptosis via FGFR3/PI3k/Akt Signaling Pathway After Subarachnoid Hemorrhage. | Mol Neurobiol | 2019 | https://conductscience.org/library/papers/31203572 | PubMed |
| 18 | 31238539 | Protein Kinase B and Extracellular Signal-Regulated Kinase Inactivation is Associated with Regorafenib-Induced Inhibition of Osteosarcoma Progression In Vitro and In Vivo. | J Clin Med | 2019 | https://conductscience.org/library/papers/31238539 | PubMed |
| 19 | 26999418 | Metastatic osteosarcoma: a challenging multidisciplinary treatment. | Expert Rev Anticancer Ther | 2016 | https://conductscience.org/library/papers/26999418 | PubMed |
| 20 | 19197972 | Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. | Cancer | 2009 | https://conductscience.org/library/papers/19197972 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42179886 | Immunotherapy and postoperative bone defect repair strategies based on osteosarcoma tumor microenvironment characteristics: balancing antitumor effects and promotion of bone regeneration. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42179886 | PubMed |
| 42015273 | The predictive value and clinical application of measuring circulating endothelial progenitor cells in lung adenocarcinoma. | J Cardiothorac Surg | 2026 | https://conductscience.org/library/papers/42015273 | PubMed |
| 41892359 | Cell-Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma. | Cells | 2026 | https://conductscience.org/library/papers/41892359 | PubMed |
| 41530253 | Proteomic analysis of endothelial progenitor cells secretome identifies Serpine 1 as a potent regulator of osteogenesis. | Sci Rep | 2026 | https://conductscience.org/library/papers/41530253 | PubMed |
| 40779492 | Daraxonrasib, a pan-RAS inhibitor, selectively inhibits osteosarcomas with activated KRAS by halting AKT signaling and matrix metalloprotease activity. | PLoS One | 2025 | https://conductscience.org/library/papers/40779492 | PubMed |
| 40507962 | Building a Therapeutic Bridge Between Dogs and Humans: A Review of Potential Cross-Species Osteosarcoma Biomarkers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40507962 | PubMed |
| 38591009 | CircTMEM165 facilitates endothelial repair by modulating mitochondrial fission via miR-192/SCP2 in vitro and in vivo. | iScience | 2024 | https://conductscience.org/library/papers/38591009 | PubMed |
| 37986615 | Endothelial progenitor cells in pregnancy-related diseases. | Clin Sci (Lond) | 2023 | https://conductscience.org/library/papers/37986615 | PubMed |
| 37511127 | Deciphering the Signaling Mechanisms of Osteosarcoma Tumorigenesis. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37511127 | PubMed |
Genes41
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36980704
GET https://conductscience.org/api/papers/v1/36980704/references?page=2